Macfarlane Group (MACF) H2 2025 earnings summary

Executive summary

• Revenue grew 11% year-over-year to £300.8m, mainly from acquisitions, while organic growth was 1%.

• Adjusted operating profit declined 28% to £19.7m, with adjusted profit before tax down 38%, mainly due to margin pressure and increased costs.

• The Pitreavie acquisition underperformed due to a tragic incident, resulting in a loss instead of the expected profit.

• Dividend maintained at 2024 levels and share buyback programme ongoing, reflecting management's confidence in recovery.

• Strong cash generation and a robust balance sheet, with net debt at GBP 16.2 million, well within banking facilities.

Financial highlights

• Revenue increased by GBP 30.4 million, with GBP 28.1 million from acquisitions and GBP 2.3 million organic.

• Adjusted operating profit fell 28% year-over-year to £19.7m; adjusted profit before tax dropped to £15.6m.

• Gross margin in distribution dropped from 37.2% to 35.3% due to competitive pressures.

• Operating expenses rose by GBP 14.5 million, with GBP 9.6 million from acquisitions and GBP 3.6 million from employee costs.

• Net debt increased to GBP 16.2 million from GBP 1.9 million, but remains under 1x Net debt to EBITDA.

Outlook and guidance

• 2026 expected to remain challenging, with market conditions at the bottom of the cycle for 12–18 months.

• Recovery plan underway, targeting a return to 7.5–8% return on sales in distribution over 2–3 years.

• Profit growth anticipated in 2026, with H2 expected to outperform H1 as Pitreavie recovers.

• No acquisitions planned for 2026; focus on organic growth, cost control, and improving Packaging Distribution performance.

• Continued development of specialist Manufacturing Operations and targeted cost savings.